NFKB1 and cancer: The canonical and alternative (non-canonical) NF-κB signaling pathways (Supplementary Figure 1) are critical for multiple aspects of cancer cell and TME biology, including chemokine production, resulting in multiple efforts to target this pathway in cancer therapy (24, 25).